254 related articles for article (PubMed ID: 37810892)
21. Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis.
Teo E; Hassan N; Tam W; Koh S
Diabetologia; 2022 Apr; 65(4):604-619. PubMed ID: 35141761
[TBL] [Abstract][Full Text] [Related]
22. Continuous glucose monitoring systems for type 1 diabetes mellitus.
Langendam M; Luijf YM; Hooft L; Devries JH; Mudde AH; Scholten RJ
Cochrane Database Syst Rev; 2012 Jan; 1(1):CD008101. PubMed ID: 22258980
[TBL] [Abstract][Full Text] [Related]
23. Knowledge Structure and Emerging Trends of Telerehabilitation in Recent 20 Years: A Bibliometric Analysis
Zheng J; Hou M; Liu L; Wang X
Front Public Health; 2022; 10():904855. PubMed ID: 35795695
[TBL] [Abstract][Full Text] [Related]
24. THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL.
Helleputte S; De Backer T; Calders P; Pauwels B; Shadid S; Lapauw B
Endocr Pract; 2021 Jan; 27(1):44-50. PubMed ID: 33475500
[TBL] [Abstract][Full Text] [Related]
25. Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.
Jones LV; Ray A; Moy FM; Buckley BS
Cochrane Database Syst Rev; 2019 May; 5(5):CD009613. PubMed ID: 31120549
[TBL] [Abstract][Full Text] [Related]
26. The evolution of minimal residual disease: key insights based on a bibliometric visualization analysis from 2002 to 2022.
Yu Z; Xie L; Zhang J; Lin H; Niu T
Front Oncol; 2023; 13():1186198. PubMed ID: 37534257
[TBL] [Abstract][Full Text] [Related]
27. Global Trends and Research Hotspots of Exercise for Intervening Diabetes: A Bibliometric Analysis.
Zhang Z; Zhu Y; Wang Q; Chang T; Liu C; Zhu Y; Wang X; Cao X
Front Public Health; 2022; 10():902825. PubMed ID: 35875005
[TBL] [Abstract][Full Text] [Related]
28. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
[TBL] [Abstract][Full Text] [Related]
29. Bibliometric analysis of tumor necrosis factor in post-stroke neuroinflammation from 2003 to 2021.
Zhao Y; Zhu Q; Bi C; Yuan J; Chen Y; Hu X
Front Immunol; 2022; 13():1040686. PubMed ID: 36389810
[TBL] [Abstract][Full Text] [Related]
30. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
[TBL] [Abstract][Full Text] [Related]
31. Inpatient Continuous Glucose Monitoring and Glycemic Outcomes.
Levitt DL; Silver KD; Spanakis EK
J Diabetes Sci Technol; 2017 Sep; 11(5):1028-1035. PubMed ID: 28290224
[TBL] [Abstract][Full Text] [Related]
32. Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: A systematic review and meta-analysis of randomised controlled trials.
Elbalshy M; Haszard J; Smith H; Kuroko S; Galland B; Oliver N; Shah V; de Bock MI; Wheeler BJ
Diabet Med; 2022 Aug; 39(8):e14854. PubMed ID: 35441743
[TBL] [Abstract][Full Text] [Related]
33. Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes.
Mulinacci G; Alonso GT; Snell-Bergeon JK; Shah VN
Diabetes Technol Ther; 2019 Jan; 21(1):6-10. PubMed ID: 30575413
[TBL] [Abstract][Full Text] [Related]
34. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.
Golden SH; Sapir T
J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955
[TBL] [Abstract][Full Text] [Related]
35. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol.
Feig DS; Asztalos E; Corcoy R; De Leiva A; Donovan L; Hod M; Jovanovic L; Keely E; Kollman C; McManus R; Murphy K; Ruedy K; Sanchez JJ; Tomlinson G; Murphy HR;
BMC Pregnancy Childbirth; 2016 Jul; 16(1):167. PubMed ID: 27430714
[TBL] [Abstract][Full Text] [Related]
36. Emerging trends and hotspots in metabolic dysfunction-associated fatty liver disease (MAFLD) research from 2012 to 2021: A bibliometric analysis.
Liao Y; Wang L; Liu F; Zhou Y; Lin X; Zhao Z; Xu S; Tang D; Jiao Y; Yang L; Yu W; Gao P
Front Endocrinol (Lausanne); 2023; 14():1078149. PubMed ID: 36761200
[TBL] [Abstract][Full Text] [Related]
37. Role of continuous glucose monitoring for type 2 in diabetes management and research.
Vigersky R; Shrivastav M
J Diabetes Complications; 2017 Jan; 31(1):280-287. PubMed ID: 27818105
[TBL] [Abstract][Full Text] [Related]
38. The effect of do-it-yourself real-time continuous glucose monitoring on psychological and glycemic variables in children with type 1 diabetes: A randomized crossover trial.
Elbalshy MM; Styles S; Haszard JJ; Galland BC; Crocket H; Jefferies C; Wiltshire E; Tomlinson P; de Bock MI; Wheeler BJ
Pediatr Diabetes; 2022 Jun; 23(4):480-488. PubMed ID: 35253331
[TBL] [Abstract][Full Text] [Related]
39. Best friend or spy: a qualitative meta-synthesis on the impact of continuous glucose monitoring on life with Type 1 diabetes.
Messer LH; Johnson R; Driscoll KA; Jones J
Diabet Med; 2018 Apr; 35(4):409-418. PubMed ID: 29247556
[TBL] [Abstract][Full Text] [Related]
40. The clinical utility of professional continuous glucose monitoring by pharmacists for patients with type 2 diabetes.
Ulrich H; Bowen M
J Am Pharm Assoc (2003); 2021; 61(6):e76-e82. PubMed ID: 34154906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
